Triple-negative breast cancer
Dark Sweet Cherries Against Breast Cancer
Pictured above: Giuliana Noratto, Ph.D., (left) and Lauren Stranahan, Ph.D., led research showing that compounds in dark sweet cherries may help slow the growth and
My Journey with Ehlers-Danlos Syndrome
Faye’s Journey with Amyloidosis
Setmelanotide Shows Limited Efficacy in Heterozygous Obesity Gene Carriers
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
Breast Cancer
Japan Advances Targeted Breast Cancer Treatment: Daiichi Sankyo Seeks Approval for Innovative Therapy After Surgery
Daiichi Sankyo has taken a significant step toward expanding treatment options in Japan by submitting regulatory approval for Enhertu, an advanced cancer-fighting drug designed to
Asthma
FDA Clears First Independent Generic of GSK’s Flovent Asthma Inhaler
As reported by FiercePharma, the U.S. Food and Drug Administration has approved the first fully independent generic version of GlaxoSmithKline’s widely used asthma inhaler, Flovent,
Trimethylaminuria
My Journey, My Life, My Story, My Book – Carry’s Experiences with “Fish Odor Syndrome”
You can not see, hear, or touch my rare condition. I STINK! (LITERALLY) I wasn’t sure if I was going to tell my story. But
HIV/AIDS
Scientists Redesign HIV-Fighting Antibodies to Strike Faster: A New Engineering Breakthrough
Researchers have created a fundamentally new class of HIV-fighting molecules by combining two separate antiviral mechanisms into a single engineered protein. Early laboratory results, reported
Psoriatic Arthritis
Bimzelx Outperforms Skyrizi in Psoriatic Arthritis Trial, Though Commercial Impact Remains Unclear
As reported on BioPharmaDive, UCB has reported positive results from a head-to-head clinical trial showing that its anti-inflammatory biologic Bimzelx was more effective than AbbVie’s
Colorectal cancer
Skipping A Colonoscopy Almost Cost Me Everything
Editor’s Note: Patient Worthy is proud and honored to share Jennifer’s story with cystic fibrosis and colon cancer, originally published on the Cystic Fibrosis Research
Seizures
Momentum Builds Across Biotech Pipeline: Seizure Breakthrough, Cell Therapy Revival, and Obesity Medicine Gains
The biotechnology sector experienced significant positive developments this week, with Xenon Pharmaceuticals’ seizure medication achieving a decisive late-stage victory while regulatory pathways accelerated for several
Breast Cancer
GLP-1 Receptor Agonists and Breast Cancer: Promising Signals, Pressing Questions
As reported on Healio, glucagon-like peptide-1 (GLP-1) receptor agonists, best known for treating diabetes and obesity, are emerging as unexpected players in breast cancer care.
Triple-negative breast cancer
Study: Engineered Immune Cells and Targeted Treatments May Slow the Spread of Triple-Negative Breast Cancer
CAR T- cells are immune cells that are engineered in a laboratory to attack cancer. The therapy has worked as planned for certain blood cancers
BRCA-mutated Breast Cancer
Breakthrough DNA Repair Inhibitor Advances Rapidly Toward Clinic: Artios’ ART6043 Earns FDA Fast Track Status for Resistant Breast Cancer
Artios Pharma has achieved a significant milestone in cancer treatment development with the U.S. Food and Drug Administration’s granting of Fast Track designation to ART6043,
Multiple Myeloma
Bristol Myers Squibb Reports Positive Phase 3 Data for Mezigdomide-Based Oral Regimen in Relapsed or Refractory Multiple Myeloma
As reported on drugs.com, Bristol Myers Squibb (BMS) has announced encouraging interim results from the Phase 3 portion of the SUCCESSOR-2 clinical trial evaluating oral
Hunter Syndrome
FDA Explains Rejection of Regenxbio’s Hunter Syndrome Gene Therapy
As reported on FierceBioTech, the U.S. Food and Drug Administration has released its complete response letter (CRL) detailing why it declined to approve Regenxbio’s experimental
Breast Cancer
Roche’s Phase III persevERA Trial of Giredestrant Misses Primary Endpoint in Advanced ER-Positive Breast Cancer
As covered on PharmaBiz, Roche has reported topline results from the phase III persevERA Breast Cancer study, which evaluated the oral selective oestrogen receptor degrader
Rare Disease
BASELINE
Editor’s Note: Patient Worthy is proud to share this article from our friends at the Courageous Parents Network. A parent often can sense when there
Breast Cancer
Daiichi Sankyo Advances Enhertu for High-Risk Breast Cancer: New Hope After Neoadjuvant Therapy
Daiichi Sankyo has taken a significant step forward in expanding treatment options for early-stage breast cancer patients by submitting a supplemental New Drug Application (sNDA)
Psoriatic Arthritis
FDA Approves BMS’s Sotyktu for Psoriatic Arthritis
As reported in a recent article by Pharmaceutical Technology, Bristol Myers Squibb (BMS) has secured US Food and Drug Administration (FDA) approval for Sotyktu (deucravacitinib)
Brain Cancer
Learning Her Again: A Mother’s Understanding of Baseline
Editor’s Note: Patient Worthy is honored to share this caregiver story with you, originally written by Aisling Melton, Parent Champion at Courageous Parents Network. In
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
We're honored to share Heather's story as a caregiver for her husband Nathan, who is living with Huntington's disease. Read here:
patientworthy.com/2026/03/28/heather-and-nathans-journey-with-huntingtons-disease/
#PatientWorthy #shareyourstory #PatientStory #HD #huntingtons #HuntingtonsDisease
Colorectal Cancer Awareness Month: Colorectal cancer is preventable, treatable, and survivable—especially when caught early. Swipe through these 5 important facts about prevention, screening, and advances in treatment. #ColorectalCancerAwarenessMonth #colorectalcancer #FactFriday #PatientWorthy
#shareyourstory with us here: bit.ly/4dV7gru
Understanding Testing for Non-Small Cell Lung Cancer with HER2 Mutation- ✨
When diagnosed with NSCLC, testing for genetic mutations like HER2 is key too choosing the right treatment. From biopsies to advanced tests like NGS & FISH, identifying the HER2 mutation helps doctors target therapies that can make a difference. #LungCancerAwareness #HER2Mutation #PatientWorthy
